Denali Therapeutics Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
South San Francisco, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Denali Therapeutics Inc. has filed 775 SEC EDGAR filings since 08 Sep 2017

SEC filing history

Showing 251-275 of 775 matching filings.

Per page
25
Current page
11
4

FORM 4

Filing date
17 Aug 2023
Reporting date
15 Aug 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
16 Aug 2023
Reporting date
14 Aug 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
16 Aug 2023
Reporting date
14 Aug 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38311

144 filing

Filing date
15 Aug 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
14 Aug 2023
Reporting date
10 Aug 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
14 Aug 2023
Reporting date
10 Aug 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
14 Aug 2023
Reporting date
10 Aug 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38311

144 filing

Filing date
14 Aug 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38311

144 filing

Filing date
14 Aug 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38311

144 filing

Filing date
10 Aug 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38311

144 filing

Filing date
10 Aug 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38311

144 filing

Filing date
10 Aug 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
19 Jul 2023
Reporting date
17 Jul 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
19 Jul 2023
Reporting date
17 Jul 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38311

144 filing

Filing date
18 Jul 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38311

144 filing

Filing date
17 Jul 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
30 Jun 2023
Reporting date
28 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38311

144 filing

Filing date
28 Jun 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
20 Jun 2023
Reporting date
16 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38311

144 filing

Filing date
16 Jun 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
05 Jun 2023
Reporting date
01 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
05 Jun 2023
Reporting date
01 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .